Rivus Pharmaceuticals has filed a notice of an exempt offering of securities to raise $66,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Rivus Pharmaceuticals is raising up to $66,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Allen Cunningham played a…
